lifitegrast
lifitegrast is used to treat the signs and symptoms of dry eye disease. It is an FDA approved drug indicated. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. Reference standards of Lifitegrast API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Lifitegrast - API Standards
[catalogue_number] => PA 39 04000
[category_ids] => ,79,80,78,70,82,88,
[chemical_name] =>
[weight] => 615.48
[form] => C29H24Cl2N2O7S
[cas] => 1025967-78-5
[pslug] => 1025967-78-5-lifitegrast-api-pa3904000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Lifitegrast - API Standards
Catalogue No.:PA 39 04000
Molecular Formula : C29H24Cl2N2O7S
Molecular Weight : 615.48
stdClass Object
(
[pname] => 5,7-Dichloro-1,2,3,4-Tetrahydroisoquinoline-6-Carboxylic Acid Hydrochloride
[catalogue_number] => PA 39 0041011
[category_ids] => ,79,80,78,70,82,88,
[chemical_name] =>
[weight] => 282.55
[form] => C10H10Cl3NO2
[cas] => 1289646-93-0
[pslug] => 1289646-93-0-5-7-dichloro-1-2-3-4-tetrahydroisoquinoline-6-carboxylic-acid-hydrochloride-pa390041011
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
5,7-Dichloro-1,2,3,4-Tetrahydroisoquinoline-6-Carboxylic Acid Hydrochloride
Catalogue No.:PA 39 0041011
Molecular Formula : C10H10Cl3NO2
Molecular Weight : 282.55